145498-86-8 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 2-(cyanoMethyl)-3-Methoxybenzoate is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs and medicinal compounds. Its unique structure allows for the creation of a variety of pharmaceutical agents, enhancing the range of treatments available for various medical conditions.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 2-(cyanoMethyl)-3-Methoxybenzoate is utilized as a precursor in the production of agrochemicals, contributing to the development of pesticides, herbicides, and other agricultural chemicals. Its role in this industry is crucial for enhancing crop protection and improving agricultural yields.
Used in Organic Synthesis:
Methyl 2-(cyanoMethyl)-3-Methoxybenzoate is used as a building block in organic synthesis for the production of a wide array of chemicals and materials. Its structural properties make it a valuable component in the synthesis of complex organic compounds, facilitating the creation of new materials with diverse applications across various industries.
Used in Research and Development:
Methyl 2-(cyanoMethyl)-3-Methoxybenzoate is also used in pharmaceutical research and development, where it serves as a key component in the exploration of new drug candidates and the advancement of pharmaceutical science. Its potential applications in this field highlight its importance in the ongoing pursuit of innovative treatments and therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 145498-86-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,5,4,9 and 8 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 145498-86:
(8*1)+(7*4)+(6*5)+(5*4)+(4*9)+(3*8)+(2*8)+(1*6)=168
168 % 10 = 8
So 145498-86-8 is a valid CAS Registry Number.
145498-86-8Relevant academic research and scientific papers
Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
-
Page/Page column 32, (2008/06/13)
The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
